NCT02094508View on ClinicalTrials.gov

Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda

CompletedOBSERVATIONAL
Enrollment

173

Participants

Timeline

Start Date

March 7, 2014

Primary Completion Date

December 28, 2015

Study Completion Date

December 14, 2016

Conditions
Malaria
Trial Locations (1)

Unknown

Rakai Health Sciences Program Uganda Virus Research Institute, Kalisizo

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02094508 - Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda | Biotech Hunter | Biotech Hunter